Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-18

Clinical Trial Update: Opening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe Asthma [Phase 3]

View source ↗

Summary

This update covers a Phase 3 trial of tezepelumab for patients with asthma and chronic rhinosinusitis with nasal polyps, focusing on its potential effects in th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tezspire (tezepelumab)

Snippet

Sponsor: Dr. Andrew Thamboo, MD | Conditions: Asthma, Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | Status: NOT_YET_RECRUITING